Fig. 2. Flow chart of study.

^*These seven patients were included in both groups due to presence of sufficient and insufficient ablative margins for multiple tumors, ^†One patient was excluded due to follow-up loss before one-month follow-up CT scan for confirming technical efficacy, ^‡One patient was excluded due to failure of achieving technical efficacy on one-month follow-up CT scan. n = number of patients, TACE = transarterial chemoembolization